Imperial College London

DrDipenderGill

Faculty of MedicineSchool of Public Health

Clinical Research Fellow
 
 
 
//

Contact

 

+44 (0)7904 843 810dipender.gill

 
 
//

Location

 

School of a Public HealthMedical SchoolSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Larsson:2021:10.1183/13993003.03545-2020,
author = {Larsson, SC and Burgess, S and Gill, D},
doi = {10.1183/13993003.03545-2020},
journal = {European Respiratory Journal},
pages = {1--3},
title = {Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia},
url = {http://dx.doi.org/10.1183/13993003.03545-2020},
volume = {57},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Respiratory disease is a main feature of severe COVID-19, and the potential of IL-6 receptor blockade to increase risk of pneumonia warrants vigilance and caution in their application to treat COVID-19.
AU - Larsson,SC
AU - Burgess,S
AU - Gill,D
DO - 10.1183/13993003.03545-2020
EP - 3
PY - 2021///
SN - 0903-1936
SP - 1
TI - Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia
T2 - European Respiratory Journal
UR - http://dx.doi.org/10.1183/13993003.03545-2020
UR - https://www.ncbi.nlm.nih.gov/pubmed/33214204
UR - https://erj.ersjournals.com/content/early/2020/11/05/13993003.03545-2020
UR - http://hdl.handle.net/10044/1/84455
VL - 57
ER -